Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction Program

Article English OPEN
Kansal, Anuraag R.; Krotneva, Stanimira; Tafazzoli, Ali; Patel, Harshali K.; Borer, Jeffrey S.; Böhm, Michael; Komajda, Michel; Maya, Juan; Tavazzi, Luigi; Ford, Ian; Kielhorn, Adrian;
  • Publisher: Taylor & Francis

Objective: The introduction of the Hospital Readmission Reduction Program (HRRP) has led to renewed interest in developing strategies to reduce 30 day readmissions among patients with heart failure (HF). In this study, a model was developed to investigate whether the ad... View more
  • References (16)
    16 references, page 1 of 2

    9. Dharmarajan K, Hsieh AF, Lin Z, et al. Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions. BMJ 2013;347:f6571

    10. Bradley EH, Curry L, Horwitz LI, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes 2013;6:444-50

    11. Feltner C, Jones CD, Cené CW, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and metaanalysis. Ann Intern Med 2014;160:774-84

    12. DeVore AD, Schulte PJ, Mentz RJ, et al. Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs. Am J Cardiol 2016;117:946-51

    13. Diaz A, Bourassa MG, Guertin M-C, Tardif J-C. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74

    14. Habal MV, Liu PP, Austin PC, et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail 2014;7:12-20

    15. Corlanor [package insert]. Thousand Oaks, CA: Amgen Inc.; 2015

    16. Swedberg K, Komajda M, Böhm M, et al; on behalf of the SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebocontrolled study. Lancet 2010;376:875-85

    17.Borer JS, Böhm M, Ford I, et al; on behalf of the SHIFT Investigators. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J 2012;33:2813-20

    18.INGENIX, a comprehensive guidebook to the MS-DRG classification system, appendix E. National Average Payment Table. DRG Expert 2010-2013. Available at: [Last accessed 12 March 2015]

  • Metrics
Share - Bookmark